Stockreport

Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds [Yahoo! Finance]

Sonnet BioTherapeutics Holdings, Inc.  (SONN) 
PDF company developing targeted immunotherapeutic drugs, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to [Read more]